The present invention relates to 2-hydroxy-alkylamino-benzoic acid derivatives and to a combination of cell necrosis inhibitor and lithium, process for the preparation of the derivatives or the combination, pharmaceutical formulation containing the derivatives or the combination, and use of the derivatives or the combination by either concomitant or sequential administration for improvement of treatment of neuronal death or neurological dysfunction. The derivatives and the combination of the present invention are useful for treating neurological diseases, such as amyotrophic lateral sclerosis (ALS, Lou Gehrig's disease), spinal muscular atrophy, Alzheimer's disease, Parkinson's disease, Huntington's disease, stroke, traumatic brain injury or spinal cord injury; and for treating ocular diseases such as glaucoma, diabetic retinopathy or macular degeneration.
本发明涉及2-羟基-烷基
氨基
苯甲酸衍
生物及细胞坏死
抑制剂和
锂的组合物,以及制备该衍
生物或组合物的过程,含有该衍
生物或组合物的制药配方,以及通过同时或顺序给药使用该衍
生物或组合物以改善神经元死亡或神经功能障碍的治疗。本发明的衍
生物和组合物对于治疗神经系统疾病,如肌萎缩侧索硬化症(
ALS,路易·格里格病)、脊髓性肌萎缩症、阿尔茨海默病、帕
金森病、亨廷顿病、中风、创伤性脑损伤或脊髓损伤;以及治疗眼科疾病,如青光眼、糖尿病性视网膜病变或黄斑变性有用。